Skip to content

Type: Virtual Meeting

Unlocking Next-Generation Therapies

Thursday, May 20, 2027 9:00AM – 2:00PM ET The Ritz-Carlton 1150 22nd St NW, Washington, DC 20037  Register   Friends of Cancer Research (Friends) and the Parker Institute for Cancer Immunotherapy (PICI) is hosting a public meeting to explore opportunities to advance next-generation therapies, including innovative approaches in cell therapy development. Stay tuned for updates.

Advancing the Future of Diagnostics and Regulatory Innovations

Wednesday, February 24, 2027 9:00AM – 2:00PM ET The Ritz-Carlton 1150 22nd St NW, Washington, DC 20037  Register   Friends of Cancer Research (Friends) is hosting a public meeting, Advancing the Future of Diagnostics and Regulatory Innovations. Stay tuned for updates.

Friends of Cancer Research Annual Meeting 2027

Tuesday, November 2, 2027 10:00AM – 3:00PM ET The Ritz-Carlton 1150 22nd St NW, Washington, DC 20037  Register Friends of Cancer Research (Friends) is proud to host our 20th Annual Meeting on November 2, 2027. Since 2007, Friends has brought together leaders across federal health and regulatory agencies, academic research, industry, and patient advocates to…

Optimizing Dosing for Radiopharmaceutical Therapies Webinar 

Tuesday, September 15, 2026 1:00PM – 2:00PM ET Location: Virtual Click to Watch White Paper  Panelist Biographies Friends of Cancer Research (Friends) hosted a public webinar to examine approaches to optimizing dosing strategies for radiopharmaceutical therapies (RPTs) as their use continues to expand across oncology. While RPTs offer significant therapeutic potential, determining appropriate dosing remains…

Interpreting Interim Overall Survival (OS) for Decision-Making Webinar

Wednesday, July 15, 2026 1:00PM – 2:00PM ET Location: Virtual Click to Watch  Project Overview One Pager  Panelist Biographies The use of OS as a safety endpoint is receiving increasing attention in oncology drug development, and there is a growing need for evidence-based approaches to guide both trial design and interpretation of these data. Friends…

Virtual Hill Briefing: Strengthening FDA’s Biomarker Qualification Program

Tuesday, June 9, 2026 1:00PM – 2:00PM ET Location: Virtual Click to Watch  White Paper   Panelist Biographies Friends of Cancer Research (Friends) hosted a Virtual Hill Briefing exploring opportunities to strengthen the FDA’s Biomarker Qualification Program (BQP). The BQP was designed to support broader use of biomarkers across development programs, but experience to date shows…

Advocates Webinar: Annual Meeting 2026

Tuesday, November 17, 2026 1:00PM – 2:00PM ET Location: Virtual Register Today Friends of Cancer Research (Friends) will host an advocate-focused webinar on November 17, following our 19th Annual Meeting on Tuesday, November 10, to translate key discussions into accessible insights for patient advocates. The Annual Meeting topics focus on early-phase oncology drug development. Early-phase…

Advancing Patient Advocacy for Spanish-Speaking Communities Through Accessible Education

Monday, March 9, 2026 1:00PM – 2:00PM ET Location: Virtual Click to Watch Friends of Cancer Research (Friends) hosted a free webinar to mark the launch of ProgresoparaPacientes.org, a new patient advocacy education program for Spanish-speaking communities. The course provides an overview of the drug development and regulatory landscape, including FDA’s role, clinical trial phases,…

Friends of Cancer Research Annual Meeting 2026

  Tuesday, November 10, 2026 10:00AM – 3:00PM ET The Ritz-Carlton 1150 22nd St NW, Washington, DC 20037  Register Friends of Cancer Research (Friends) is proud to host our 19th Annual Meeting on November 10, 2026. Since 2007, Friends has brought together leaders across federal health and regulatory agencies, academic research, industry, and patient advocates…

Advocates Webinar: Unlocking Next-Generation Therapies

Thursday, June 11, 2026 1:00PM – 2:00PM ET Location: Virtual Click to Watch Friends of Cancer Research (Friends) hosted a webinar for advocates on June 11th at 1PM ET that focused on topics in cell and gene therapy development, including early-phase clinical trials, manufacturing, and clinical trial designs and evidence generation. Panelists provided background on…